Is Eli Lilly's Latest Deal a Gamechanger?
One of the biggest contributors to growth in the pharmaceutical industry right now is weight-loss medicine. Diabetes and obesity treatments from Novo Nordisk, such as Ozempic, Rybelsus, and Wegovy, are taking the world by storm. Eli Lilly (NYSE: LLY) is …